Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS · Delayed Price · Currency is USD
0.1831
-0.4569 (-71.39%)
At close: May 8, 2026
Ampio Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
207.88K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Carisma Therapeutics | 52.63M |
| Zenith Capital | 500.00K |
| Lipella Pharmaceuticals | 389.78K |
| Endonovo Therapeutics | 255.72K |
| GB Sciences | 97.24K |
| CNBX Pharmaceuticals | 40.64K |
| THC Farmaceuticals | 18.52K |
Ampio Pharmaceuticals News
- 2 years ago - Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation - PRNewsWire
- 2 years ago - Ampio Announces Voluntary Delisting and SEC Deregistration - PRNewsWire
- 2 years ago - Ampio Provides Update on Results from Pre-IND Enabling Studies - PRNewsWire
- 2 years ago - Ampio Pharmaceuticals Announces At-The-Market Stock Offering - TipRanks
- 2 years ago - Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions - PRNewsWire
- 2 years ago - Ampio Pharmaceuticals to Present at the Emerging Growth Conference - PRNewsWire
- 2 years ago - Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 - PRNewsWire
- 3 years ago - Ampio Pharmaceuticals Announces Reverse Stock Split - PRNewsWire